The efficacy and safety of weekly 35-mg risedronate dosing regimen for Chinese postmenopausal women with osteoporosis or osteopenia: 1-year data

被引：0
|
作者：
Jie-mei Gu
Li Wang
Hua Lin
De-cai Chen
Hai Tang
Xiao-lan Jin
Wei-bo Xia
Yun-qiu Hu
Wen-zhen Fu
Jin-wei He
Hao Zhang
Chun Wang
Hua Yue
Wei-wei Hu
Yu-juan Liu
Zhen-lin Zhang
机构：
[1] Metabolic Bone Disease and Genetic Research Unit,Department of Osteoporosis and Bone Diseases
[2] Shanghai Jiao Tong University Affiliated Sixth People's Hospital,Department of Endocrinology
[3] Lab of Osteoporosis,Department of Orthopaedics
[4] Tianjin Hospital,Department of Endocrinology
[5] The Center of Research for Metabolic Bone Disease and The Affiliated Drum Tower Hospital of Medical School,Department of Endocrinology
[6] Nanjing University,undefined
[7] West China Hospital,undefined
[8] Sichuan University,undefined
[9] Beijing Shunyi Hospital,undefined
[10] General Hospital of People's Liberation Army Chengdu Military Region,undefined
[11] Key Laboratory of Endocrinology,undefined
[12] Ministry of Health,undefined
[13] Peking Union Medical College Hospital,undefined
[14] Chinese Academy of Medical Science,undefined
来源：
Acta Pharmacologica Sinica | 2015年 / 36卷
关键词：
risedronate; pyridinyl bisphosphonate; postmenopausal osteoporosis; bone density; biological markers; adverse reaction; drug administration schedule; double-blind method; female;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：841 / 846
页数：5
相关论文
共 27 条
  • [21] SUSTAINED P1NP SUPPRESSION WITH MONTHLY 150 MG RISEDRONATE TREATMENT OF POSTMENOPAUSAL WOMEN WITH LOW BONE MASS DURING 1 YEAR TREATMENT ANALYSIS AND EVALUATION OF RISK OF FALLING IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Riera-Espinoza, G.
    Cordero, Y.
    Mendoza, S.
    Gonzalez, Y.
    Ramos, J.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S244 - S245
  • [22] Efficacy of fosavance 5600® (once weekly alendronate 70 mg & vitamin D3 5600 iu combination) relative to risedronate 35 mg weekly for the prevention of fractures in postmenopausal osteoporosis:: Results of a mixed-treatment indirect comparison meta-analysis
    Bergman, G. J. D.
    Fan, T.
    Sen, S. S.
    Jansen, J. P.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S223 - S224
  • [23] COMPARISON OF THE EFFICACY AND SAFETY OF A SINGLE INFUSION OF ZOLEDRONIC ACID 5 MG WITH DAILY ORAL RISEDRONATE 5 MG IN PATIENTS WITH GLUCOCORTICOID-INDUCED OSTEOPOROSIS: RESULTS FROM A 1-YEAR RANDOMISED, DOUBLE-BLIND TRIAL
    Reid, David M.
    Devogelaer, Jean-Pierre
    Saag, Kenneth
    Keen, Richard
    Roux, Christian
    Lau, Chak Sing
    Reginster, Jean-Yves
    Papanastasiou, Philemon
    Fashola, Taiwo
    Mesenbrink, Peter
    Sambrook, Philip
    [J]. RHEUMATOLOGY, 2009, 48 : I105 - I106
  • [24] Efficacy and safety of the contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive in Chinese women: a 1-year randomised trial
    Fan, Guang Sheng
    Ren, Mulan
    Di, Wen
    Su, Ping
    Chang, Qin
    Wu, Shuying
    Qin, Yun
    Korver, Tjeerd
    Marintcheva-Petrova, Maya
    Yacik, Carol
    Sisk, Christine McCrary
    Wang, Guoqin
    [J]. EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2016, 21 (04): : 303 - 309
  • [25] Odanacatib Efficacy and Safety in Postmenopausal Women with Osteoporosis: 5-Year Data from the Extension of the Phase 3 Long-Term Odanacatib Fracture Trial
    McClung, Michael R.
    Langdahl, Bente
    Papapoulos, Socrates
    Saag, Kenneth G.
    Bone, Henry
    Kiel, Douglas P.
    Lippuner, Kurt
    Nakamura, Toshitaka
    Reid, Ian
    Heyden, Norman
    DaSilva, Carolyn
    Scott, Boyd B.
    Massaad, Rachid
    Kaufman, Keith D.
    Stoch, Aubrey
    Santora, Arthur
    Gurner, Deborah
    Lombardi, Antonio
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [26] Odanacatib Efficacy and Safety in Postmenopausal Women with Osteoporosis: 5-Year Data from the Extension of the Phase 3 Long-term Odanacatib Fracture Trial (LOFT)
    McClung, Michael R.
    Langdahl, Bente
    Papapoulos, Socrates
    Saag, Kenneth G.
    Bone, Henry
    Kiel, Douglas P.
    Lippuner, Kurt
    Nakamura, Toshitaka
    Reid, Ian
    Heyden, Norman
    DaSilva, Carolyn
    Scott, Boyd B.
    Massaad, Rachid
    Kaufman, Keith D.
    Stoch, S. Aubrey
    Santora, Arthur
    Gurner, Deborah
    Lombardi, Antonio
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2016, 23 (12): : 1369 - 1369
  • [27] A comparative 2-year study of the effects of sequential regimens of 1 mg 17β-estradiol and trimegestone with a regimen containing estradiol valerate and norethisterone on the bleeding profile and endometrial safety in postmenopausal women
    Koninckx, PR
    Spielmann, D
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2005, 21 (02) : 82 - 89
123